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ABSTRACT 16 
Several studies have documented the important role of polyphenol-rich foods in the modulation of 17 
vascular remodelling and function. This study aimed to evaluate the capacity of a single portion of 18 
blueberry (V. corymbosum) to acutely improve peripheral arterial dysfunction in a group of young 19 
volunteers. 20 
Twenty-four healthy male (12 non-smokers and 12 smokers) were recruited for two different 21 
randomized, controlled, crossover pilot acute studies. In the first study, non-smokers were exposed 22 
to a control treatment (C; 300 mL of water with sugar) and a blueberry treatment (BB; 300 g of 23 
blueberry). In the second study, smokers underwent 3 different protocols: 1-smoking treatment (S); 24 
2-control treatment (CS; 300 mL of water with sugar + smoking); 3-blueberry treatment (BS; 300 g 25 
of blueberry + smoking). Each treatment (1 day long) was separated by a one week washout period. 26 
Blood pressure, peripheral arterial function (reactive hyperemia index, RHI, a marker of endothelial 27 
function) and arterial stiffness (digital augmentation index, dAix and dAix normalized by 28 
considering a heart rate of 75 bpm, dAix@75) were measured before and after each treatment.  29 
In the first study, the consumption of blueberry and control treatment acutely increased peripheral 30 
arterial function in the group of non-smokers. The improvement in RHI was higher and 31 
significantly different after blueberry treatment compared to control treatment (54.8±8.4% BB vs. 32 
28.2±8.3% C; p=0.01). No effects were observed for markers of arterial stiffness, blood pressure 33 
and heart rate.  34 
Acute cigarette smoke significantly increased blood pressure and heart rate, while no significant 35 
effect was registered in peripheral arterial function and stiffness. The intake of blueberry and 36 
control treatment before a cigarette did not counteract the increase in blood pressure and heart rate, 37 
while it significantly improved peripheral arterial function. In particular, a significant increase was 38 
observed following BS (35.2±7.5% RHI; p=0.02) and CS treatment (34.6±11.9% RHI; p=0.02) 39 
when compared to only smoking treatment. No difference between BS and CS was detected.  40 
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In conclusion, the intake of blueberry and control treatment acutely improved peripheral arterial 41 
dysfunction both in smoker and non-smoker subjects. Further studies should be performed to 42 
confirm the results obtained and reveal the potential mechanisms of blueberry in the improvement 43 
of endothelial function.  44 
Keywords: Blueberry, arterial function, arterial stiffness, blood pressure, smoker and non-smoker 45 
subjects    46 
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Introduction 47 
Endothelial dysfunction is characterized by an imbalance between vasodilator and vasoconstrictor 48 
mediators resulting in altered vascular tone, organ blood flow and peripheral vascular resistance.1 49 
The endothelium, in response to mechanical and hormonal stimuli, releases vasoconstrictor and 50 
vasodilator agents that regulate vasomotor function by inducing vasoconstriction or vasodilation.2 51 
Nitric oxide (NO) is one of the most important molecules involved in the process of vasodilation. 52 
When endothelial damage occurs, the bioavailability of NO decreases causing vasoconstriction of 53 
the endothelium.2 Endothelial dysfunction represents the first step leading to the development of 54 
atherosclerosis.1 Convincing evidence supports the pivotal role of smoking, as source of oxidative 55 
stress, in the development of ED.3 Cigarette smoke causes a temporal increase in blood pressure, 56 
heart rate and acute endothelial damage, and vascular and systemic inflammation.4  57 
Blueberries are a rich source of polyphenolic compounds such as phenolic acids and anthocyanins 58 
involved in the modulation of several functional and metabolic pathways related to endothelial 59 
function.5-8 For example, anthocyanins (ACNs) have been reported to induce the expression and 60 
activity of numerous enzymes involved in NO metabolism.7 In particular, ACNs have documented 61 
to stimulate endothelial nitric oxide synthase (eNOS) and to decrease endothelial NADPH oxidase 62 
activity and O2
.- levels as a result of haem oxygenase-induction.7 Furthermore, ACNs have been 63 
shown to reduce the expression of a plethora of pro-inflammatory agents involved in the adhesion 64 
of monocytes to endothelial cells by inhibiting redox-sensitive transcription factor NF-kB and by 65 
eliciting cell adaptive responses involving the transcription factor Nrf2.7,9-11  66 
The role of blueberries in the modulation of vascular function has been evaluated in different acute 67 
and chronic intervention studies.5,12-17 Stull et al.12 reported that a 6-week intervention with 68 
blueberries (22.5g of freeze-dried blueberry powder, providing 290 mg of anthocyanins) smoothie 69 
(twice/day) improved endothelial function in subjects with metabolic syndrome. We previously 70 
documented that a 6-week consumption of 250 mL of a wild blueberry drink (25g of freeze-dried 71 
blueberry powder, providing 375 mg of anthocyanins) failed to show an improvement of peripheral 72 
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arterial function, a marker of endothelial function, in the whole group of subjects with 73 
cardiovascular risk factors.17 The beneficial effects were documented only in smokers and in those 74 
with endothelial dysfunction.17 Recently, we showed that a serving of 300 g of blueberry purée 75 
(providing about 300 mg of anthocyanins) was able to counteract the temporary impairment of 76 
endothelial function induced by acute cigarette smoke in a group of smoker volunteers with normal 77 
endothelial function.14 Based on our previous research, we evaluated whether the consumption of 78 
the same portion of blueberries could also improve endothelial function also in subjects with a 79 
dysfunctional endothelium (single risk factor) and in those exposed to oxidative stress (smoking) 80 
and showing an impairment in peripheral arterial function (double risk factor). To this aim, two 81 
randomized, controlled, pilot studies (one in a group of smokers and the other one in non-smoker 82 
subjects) were performed in which the effect of a single blueberry portion on peripheral arterial 83 
function was evaluated.  84 
 85 
Materials and Methods 86 
Subject selection  87 
Twenty-four healthy male (12 non-smokers and 12 smokers) subjects with peripheral arterial 88 
dysfunction (RHI < 1.67) were recruited from the student population of the University of Milan 89 
according to the following criteria: 20–30 years of age, reactive hyperemia index, as marker of 90 
peripheral arterial function (RHI < 1.67), moderate physical activity (up to 25-30 min per day of 91 
brisk walk or jog) and alcohol consumption (no more than 14 drinks of wine or beer per week). 92 
Smokers were homogeneous for smoking habits (about 15 cigarettes per day). Exclusion criteria 93 
were hypertension (systolic pressure >140 mm Hg and diastolic pressure >90 mm Hg), fasting 94 
hyperglycemia (>10 mmol/L), hypercolesterolemia (high total serum cholesterol, >5.17 mmol/L; 95 
high low density lipoprotein cholesterol, >3.36 mmol/L), hypertriglyceridemia (>1.69 mmol/L), 96 
overweight/obese (BMI >25 kg/m2) based on American Heart Association guidelines.18 Subjects 97 
with normal endothelial function (RHI >1.67) were automatically excluded from the study. 98 
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Moreover, diabetic patients, subjects with renal insufficiency, constipation, diarrhea or 99 
gastrointestinal problem or diseases, were not included. Subjects with traumas of the arms or hands, 100 
fingers, atopic dermatitis, thyroid disturbance, depression, anxiety, palpitations, asthma, and chronic 101 
backache were excluded. Other exclusion criteria were as follow: allergies, high (>5 portions/day) 102 
or low (<2 portions/day) intake of fruit and vegetables, specific diet (e.g. vegetarian, vegan or 103 
macrobiotic), specific aversion to blueberries or their products, use of drugs, supplements, 104 
medications during the last month. The study was performed in accordance to the ethical standards 105 
established in the 1964 Declaration of Helsinki and approved by the Ethics Committee of the 106 
University of Milan. All participants signed the informed consent form. The study was registered at 107 
www.isrctn.org as ISRCTN59129089.  108 
 109 
Food preparation and composition 110 
Fresh blueberry (Vaccinium corymbosum L. “Brigitta”), from a single batch, was purchased and 111 
immediately stored at -20°C until use.  A portion (300 g) of frozen blueberry was thawed at +4°C 112 
overnight and provided to the participants. It contained 27 g of total sugars, 856 mg of total 113 
phenolic acids, 309 mg of total anthocyanins, 30 mg of chlorogenic acid and 2.4 mg of ascorbic 114 
acid. The control treatment was prepared by suspending 16.4 g of fructose and 10.6 g of glucose 115 
(the same amount and type of sugars contained in the blueberry) in 300 ml of water. No bioactive 116 
compounds were added.  117 
 118 
Experimental design 119 
Prior to the intervention, a 10-day run-in period was performed. Subjects were deprived of 120 
polyphenol-rich foods such as chocolate, berries, red wine and red to blue fruits, and green tea. 121 
Volunteers were asked to limit their intake of coffee to three cups per day, as well as caffeine-rich 122 
beverages (e.g. energy drinks), to reduce a potential effect on vascular function. The day before the 123 
7 
 
experiment, breakfast, lunch and dinner were standardized to provide adequate 124 
energy/macronutrient intake, taking into account Italian dietary habits.14 All participants refrained 125 
from physical activity the day before the experiment, while smokers were asked to maintain their 126 
smoking habits as reported in the questionnaire but refrain from cigarettes the morning of the 127 
experiment.  128 
Study 1- Twelve nonsmokers with peripheral arterial dysfunction were randomly divided into 2 129 
groups of 6 subjects each: group 1 was assigned to the sequence BB treatment/wash-out/C 130 
treatment, whereas group 2 followed the sequence C/wash-out/BB treatment. The study consisted of 131 
a repeated measure 2-arm randomized-controlled trial (Fig. 1A). Each protocol was separated by a 132 
7-day wash-out period. RHI levels were assessed in the morning after overnight fasting and 133 
following the consumption of 300 g blueberries or control treatment (BB or C, respectively). The 134 
protocol was designed to measure vascular function (peripheral arterial function and arterial 135 
stiffness) 120 min after blueberry/control intake by considering our previous observations on the 136 
specific time-point effect on endothelial function observed following the intake of the same portion 137 
of blueberry.14 The evaluation of peripheral arterial function and arterial stiffness was performed at 138 
baseline (T = 0) and after the intake of blueberry and control treatment (T = 120 min). Systolic (S) 139 
and diastolic (D) blood pressure (BP), and heart rate (HR) were measured in duplicate as follows: 140 
before BB and C intake (T = 0 min), after BB and C intake (T = 100 min), and following the 141 
measurements of endothelial function and arterial stiffness (T = 120 min).  142 
Study 2-Twelve smokers with peripheral arterial dysfunction were randomly assigned to 3 different 143 
groups: S- smoking treatment; BS- blueberry treatment (300 g of blueberry) + smoking; CS- control 144 
treatment (300 mL of water with sugar) + smoking. The study consisted of a repeated measure 3-145 
arm randomized-controlled trial (Fig. 1B). Each protocol was separated by a-7 day wash-out period. 146 
The day of the experiment, baseline RHI levels were assessed early in the morning after overnight 147 
fasting and without smoking. Successively, peripheral arterial function was assessed after smoking 148 
(S) or following the consumption of 300 g blueberries or control treatment and smoking (BS or CS 149 
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respectively). The protocol was designed to measure reactive peripheral arterial function and 150 
stiffness 120 min after blueberry/control intake (corresponding to 20 minutes after cigarette 151 
smoking) according to our previous publication.14 Systolic (S) and diastolic (D) blood pressure 152 
(BP), and heart rate (HR) were measured in duplicate at baseline (T = 0 min), before smoking (T = 153 
100 min), 5 min after smoking one cigarette (T = 105 min), and following the measurements of 154 
endothelial function and arterial stiffness (T = 120 min).  155 
 156 
Evaluation of blood pressure, heart rate, peripheral arterial function and arterial stiffness 157 
Peripheral arterial function was performed by a non-invasive plethysmographic method (Endo-PAT 158 
2000, Itamar Medical Ltd, Caesarea, Israel) as previously reported in detail.14 During the 159 
assessment, participants were in a supine position in a comfortable, dimly lit and temperature-160 
controlled room. After application of the occlusion cuff to the dominant arm and finger tip probes to 161 
the index fingers of each hand, the study began with a 5 minute baseline, 5 minutes of occlusion, 162 
and last 5 minutes of post-occlusion measurements (hyperemic period). Occlusion of the brachial 163 
artery was performed on the dominant upper arm (at least 60 mmHg above the systolic blood 164 
pressure; minimally 200 mmHg and maximally 300 mmHg). The Endo-PAT system generates 165 
automatically a value of reactive hyperemia index (RHI) as index of the endothelial-dependent 166 
flow-mediated dilation (FMD; gold standard method for the evaluation of endothelial function).19-20 167 
A RHI value less than 1.67 provides a sensitivity of 82% and a specificity of 77% for diagnosing 168 
endothelial dysfunction.21 The Endo-PAT device also provides dAix, strongly correlated to aortic 169 
Aix, calculated from the shape of the pulse wave recorded by the probes during baseline.22 Because 170 
Aix is influenced in an inverse and linear manner by heart rate, the dAix was automatically 171 
normalized by considering a heart rate of 75 bpm (dAix@75).  172 
 173 
Statistical analysis  174 
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The sample size was calculated taking into account the expected variation of RHI as the primary 175 
endpoint considered. Based on our previous observation,14 twelve subjects were calculated to be 176 
sufficient to evaluate a difference of RHI after a blueberry intake of 0.30 (standard deviation 0.35), 177 
with alpha = 0.05 and a statistical power of 80%. In addition, the repeated measures design reduces 178 
the variance of estimates of treatment-effects allowing to use fewer subjects. Finally, the number of 179 
subjects enrolled was comparable to that reported in other studies evaluating the role of cocoa, 180 
chocolate and mango in the modulation of endothelial function through PAT technology.23-26 181 
Results for each treatment are reported as the percentage change (i.e. [after treatment − before 182 
treatment]/before treatment × 100). Mean changes are described as a mean with 95% CI. Variables 183 
were analyzed by one way ANOVA with time or treatment as dependent factors. Differences were 184 
considered significant at p ≤ 0.05; post-hoc analysis of differences between treatments was assessed 185 
by the Least Significant Difference (LSD) test with p ≤ 0.05 as the level of statistical significance. 186 
Data are reported as mean values and standard error of the mean (SEM). Statistical analysis was 187 
performed by means of the STATISTICA software (Statsoft Inc., Tulsa, OK, US). 188 
 189 
Results 190 
Study 1  191 
Baseline characteristic of non-smoker subjects 192 
The anthropometric and clinical characteristics at baseline of the 12 healthy non-smoker subjects 193 
enrolled are reported in Table 1. All volunteers presented values of RHI lower than 1.67 (cut-off to 194 
discriminate an endothelial dysfunction). Blood pressure, heart rate and BMI were in the normal 195 
range.  196 
 197 
Effect of blueberry and control treatments on blood pressure, heart rate, arterial function and 198 
arterial stiffness in non-smokers  199 
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The mean percentage changes pre- to post-treatment following the intake of blueberry and control 200 
are presented in Table 2. Both treatments did not have a significant impact on SBP, DPB and HR.  201 
The effect of blueberry and control treatment on RHI (A), dAix (B) and dAix@75 (C) is reported in 202 
Figure 2.  Both treatments had a favorable effect on RHI showing an improvement compared to 203 
baseline (time effect). In particular, 10 out of 12 subjects (83%) reversed their RHI impairment 204 
following blueberry treatment, while 7 out of 12 subjects (58%) did similarly following the control 205 
treatment. The mean percentage change pre- to post-treatment following the BB treatment for RHI 206 
was +54.8% (95% CI: +37.9%, +71.7%) and +28.2% (95% CI: +11.5%, +44.9%) following C 207 
treatment (Fig. 2A). This increase was higher and significantly different after BB when compared to 208 
C treatment (RHI, p = 0.011; treatment effect). On the contrary, no significant effect was observed 209 
for dAix and dAix@75 as markers of arterial stiffness (Fig. 2B and 2C). 210 
 211 
Study 2 212 
Baseline characteristics of smoker subjects 213 
The anthropometric and clinical characteristics of the 12 smoker subjects enrolled are reported in 214 
Table 3. All volunteers were apparently healthy with blood pressure, heart rate and BMI in the 215 
normal range while the levels of peripheral arterial function were lower than 1.67, implying 216 
impaired peripheral arterial function.  217 
 218 
Effect of smoking on blood pressure, heart rate, arterial function and arterial stiffness in 219 
smokers. 220 
Smoking induced a significant temporary increase in the levels of SBP (from 117.1 ± 4.40 mmHg to 221 
129.6 ± 2.99 mmHg; p = 0.006), DBP (from 74.2 ± 4.00 to 83.2 ± 3.32; p = 0.03) and HR (from 222 
65.2 ± 3.58 beat min−1 to 75.3 ± 5.07 beat min−1; p = 0.04). The rise was registered after 5 min from 223 
smoking and the values dropped to baseline after 20 min (Fig. 3). Table 4 reports the levels of RHI, 224 
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dAix and dAix@75 before and after smoking. No significant effect on markers of arterial function 225 
and stiffness was observed after acute cigarette smoking.  226 
 227 
Effect of blueberry and control treatments on blood pressure, heart rate, arterial function and 228 
stiffness in smokers 229 
The effect of BS and C treatment on blood pressure and heart rate in smoker volunteers is reported 230 
in Table 5. No significant effect in the mean percentage change pre- to post-treatment was observed 231 
on SBP, DPB and HR following the three interventions (S vs. CS vs. BS). Figure 4 shows the effect 232 
of S, BS and CS treatment  on RHI (A), dAix (B) and dAix@75 (C). ANOVA revealed a significant 233 
effect of the treatment for the variable RHI (p = 0.03; Fig. 4A). In particular, the mean percentage 234 
change pre- to post-treatment was +8.38% (95% CI: −4.57%, +21.3%) following S treatment, 235 
+34.6% (95% CI: +10.6%, +58.7%) following CS treatment and +35.2% (95% CI: +20.2%, 236 
+50.3%) following BS treatment. Post-hoc analysis (LSD test) showed that consumption of a single 237 
serving of blueberry and control significantly reversed the impairment of RHI (Fig. 4B) when 238 
compared to S treatment (BS vs. S, p = 0.022 and CS vs. S, p = 0.023).  239 
However, BS and CS treatments did not differ in their effect (p = 0.954). No significant variation 240 
was detected for dAix and dAix@75 following the three treatments (Fig. 4C).  241 
 242 
Discussion 243 
Several studies have emphasized the role of polyphenol-rich foods in the modulation of vascular 244 
function. Encouraging results have been obtained following the consumption of a serving of 245 
coffee,27-28 tea,29-30 dark chocolate and cocoa powder,25,31-33 and grape,34 while few and conflicting 246 
are those reported after the intake of different types of berries.15-16, 35-38 For example, Dohadwala 247 
and colleagues documented a significant increase in vascular function 4 h after the consumption of 248 
a cranberry juice (480 ml, providing 835 mg total polyphenols and 94 mg anthocyanins) in a group 249 
of subjects with coronary artery disease.36 Rodriguez-Mateos et al.15 showed that the consumption 250 
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of blueberry baked products (containing a total of 34 g of wild blueberry powder, equivalent to 240 251 
g of fresh blueberry) improved endothelial function at 1, 2 and 6 h in healthy volunteers. In contrast, 252 
we previously failed to observe a beneficial effect on vascular function 1 h after the intake of a 253 
portion (300 g) of blueberry (providing 300 mg of anthocyanins) in young, healthy subjects with 254 
normal endothelial function.37 Also, Jin et al.,38 reported that vascular reactivity was not affected 2 255 
h from the intake of 250 ml blackcurrant juice drink in a group of healthy volunteers. In the present 256 
pilot studies, we documented that the administration of 300 g of blueberry acutely improved 257 
peripheral arterial function both in smoker and non-smoker subjects after 2 h from the consumption. 258 
Discrepancies among studies may be dependent on the type and the dose of berry (e.g. cranberry vs. 259 
blackcurrant vs. blueberry), the experimental design, and/or the subject characteristics (e.g. healthy 260 
vs. subjects with cardiovascular risk factors/endothelial dysfunction), the length of time between 261 
berry intake and the evaluation of the endothelial function (e.g. 1 h vs. 2, 4 or 6 h), and the mode of 262 
measuring endothelial function (e.g. flow mediated dilation vs. peripheral arterial function). 263 
Another important variable to be considered may be the peak time of absorption of 264 
bioactives/metabolites and their blood concentration. Rodriguez-Matheos et al.16 reported that the 265 
administration of different doses of blueberry polyphenols (766, 1278, and 1791 mg total blueberry 266 
polyphenols, equivalent to 240, 400, and 560 g fresh blueberries, respectively) increased endothelial 267 
function at 1-2 h and 6 h in a group of healthy subjects and these beneficial effects were closely 268 
linked to the increase of circulating levels of polyphenol metabolites in a time- and dose-dependent 269 
manner. In our study, we did not measure the absorption of blueberry bioactives and their metabolic 270 
products; however, we previously documented that the intake of the same blueberry portion, 271 
increased anthocyanin absorption at 1 h, reaching the maximum peak at 1.5-2 h from 272 
consumption.39 These findings could explain the modulation of endothelial function observed at 2 h 273 
in our subjects. 274 
It is widely recognized that cigarette smoking causes acute and chronic vascular damage. 275 
We reported that the smoke of one cigarette, temporarily induces vascular dysfunction in a group of 276 
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young smokers.40 In the present study, acute cigarette smoke did not further induce detrimental 277 
effects on vascular function in smokers with established endothelial dysfunction. Positively, the 278 
intake of blueberries reversed this condition, in agreement with our previous publication.14 Similar 279 
results were also reported by Schwarz and colleagues documenting that pre-consumption of red 280 
wine prevented most of the negative vascular effects of acute smoking in a group of young healthy 281 
non-smokers.41 In our study, the beneficial effects observed following the consumption of blueberry 282 
were not significantly different compared to those observed after the intake of control drink. The 283 
lack of a significant difference in RHI between blueberry and control treatment, together with the 284 
apparent increase observed also in the non-smoker group following the intake of control drink, 285 
could be attributed to different factors. For example, it has been reported that the amount and type 286 
of sugar may affect endothelial function.42-43 The consumption of both blueberry and control drink, 287 
providing the same amount of glucose and fructose, brought blood glucose to a comparable 288 
elevation within the first 15 min from intake and dropped to baseline after 1 h, as documented in a 289 
subgroup of subjects (data not shown). Since the evaluation of arterial function was performed 2 h 290 
from the intake of blueberry and control drink, we can exclude a direct contribution of sugars for 291 
the above observation. However, different studies reported a possible involvement of insulin and 292 
glucagon, two hormones secreted in response to blood sugar levels, in the modulation of vascular 293 
function especially at microvascular level.44-46 The secretion of insulin may induce changes in 294 
microcirculatory tone, activate the eNOS pathway and consequently lead to vasodilation.44-45 On the 295 
other hand, glucagon can trigger the formation of cAMP, which induces the formation of NO 296 
playing a pivotal role in vasorelaxation.46 Since PAT technology measures endothelial function at 297 
the microvascular level, and subjects did not consume food apart from the blueberry and control 298 
drinks) during the entire duration of the experiment, the involvement of insulin or glucagon cannot 299 
ruled out. 300 
Arterial stiffness represents a significant determinant of pulse pressure and elasticity of the 301 
blood vessels.47 Numerous studies found that chronic smoking increases arterial stiffness.48 The loss 302 
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of elasticity of the artery walls reduces its compensatory ability to absorb the pulsatile energy and 303 
the wave propagation effects, that influence peripheral wave reflection. This inability for 304 
compensatory response, results in the gradual increase in blood pressure with age, leading to the 305 
development of isolated systolic hypertension and to an increase of cardiovascular risk. The Endo-306 
PAT system provides the value of augmentation index (AI) and the value of digital AI, standardized 307 
for heart rate (dAI@75), as markers of arterial stiffness. Digital AI reflects changes in vessel 308 
diameter, blood pressure and heart rate.49 In our experimental conditions, we documented that the 309 
subjects involved did not show an impairment in arterial stiffness, probably due to their young age. 310 
Acute cigarette smoke, as well as the intake of a portion of blueberry, seem to be insufficient to 311 
alter  arterial stiffness in accordance with previous observations.14 However, other studies reported 312 
a significant effect following medium/long term intervention with blueberries.50-51 Johnson et al.,50 313 
showed that 8 weeks of blueberry consumption (22 g freeze-dried blueberry powder, providing 314 
about 844 mg phenolics and 470 mg anthocyanins) reduced arterial stiffness in postmenopausal 315 
women with pre- and stage 1-hypertension. McAnulty and colleagues reported that 6 weeks 316 
consumption of 25 g of a whole blueberry powder (equivalent to 250 g fresh berries, not 317 
characterized for phenolic compounds) improved arterial stiffness in sedentary men and women.51  318 
 Recent research emphasized the role blueberries in the control of blood pressure in subjects 319 
with pre-hypertension, hypertension and/or metabolic syndrome.50-53 We previously reported that 320 
the intake of a portion of blueberry was unable to affect blood pressure in a group of healthy 321 
subjects,37 while we documented  its capability to counteract the increase in systolic blood pressure 322 
induced by acute cigarette smoke.14 In the present study, we confirmed the effect of smoking on 323 
blood pressure and heart rate in accordance with the literature, but we failed to demonstrate the 324 
ability of blueberries to counterbalance this impairment, probably due to the small number of 325 
subjects enrolled. Similar results have been reported by McAnulty and colleagues that documented 326 
no significant effect on blood pressure following an acute and chronic intervention with blueberries 327 
in smokers.54  328 
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Possible study limitations are the small number of subjects, the lack of information 329 
regarding the circulating levels of insulin, glucagon and anthocyanins as potential mechanisms 330 
underpinning the improvement of endothelial function. Finally, another factor maybe the absence of 331 
a real placebo as control treatment.  332 
In conclusion, this study documented that one portion of blueberries (300 g) can acutely 333 
improve endothelial function in young smokers and non-smokers with endothelial dysfunction. 334 
Additional, acute and chronic intervention studies should be performed to confirm the results 335 
obtained and reveal the potential mechanisms of action through which blueberries can affect 336 
endothelial function. Moreover, since sugars have been shown to positively influence the 337 
endothelial response, the role of insulin and glucagon must be evaluated in the future. Even though 338 
this pilot study concludes that blueberries can overcome the endothelial dysfunction associated with 339 
cigarette smoking, the authors do encourage people to stop smoking in order to reduce all risks 340 
associated with this habit.  341 
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Table 1- Characteristics of non-smoker subjects at baseline  517 
 518 
 519 
 520 
 521 
 522 
 523 
 524 
 525 
 526 
 527 
 528 
 529 
 530 
 531 
 532 
Legend 533 
1N=12. Data are reported as mean ± SEM; SBP, systolic blood pressure; DBP, diastolic 534 
blood pressure; HR, heart rate; RHI, reactive hyperemia index; dAix, digital augmentation 535 
index; dAix@75, digital augmentation index standardized for heart rate of 75 bpm; SEM, 536 
standard error of the mean 537 
  538 
Variables         Mean ± SEM1 
Age (years)                                        24.2 ± 1.2 
Height (cm) 
Weight (kg) 
BMI (kg/m2) 
       175.8 ± 1.4 
         70.5 ± 2.1 
         22.5 ± 1.2 
SBP (mm Hg)        116.9 ± 3.2 
DBP (mm Hg)          75.3 ± 2.9 
HR (beat/min)          61.8 ± 5.3 
RHI 
dAix(%) 
dAix@75 (%) 
         1.41 ± 0.07 
         -14.6 ± 2.7 
        -20.0 ± 5.8         
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Table 2 – Mean percentage variation (Δ) of systolic blood pressure (SBP), diastolic blood pressure 
(DPB) and heart rate (HR) in non-smokers following the intake of blueberry (BB) and control (C) 
treatment.1 
 
                                     Δ% BB                   Δ% C              p value2 
SBP                             -0.89 ± 0.91             -2.93 ± 2.03        0.236 
DBP                            -2.76 ± 2.33            -1.38 ± 1.04         0.431 
HR                              -1.08 ± 1.84             0.56 ± 4.05          0.869 
 
Legend  
1 N =12. Data are expressed as means ± SEM. SBP, systolic blood pressure; DBP, diastolic blood 
pressure; HR, heart rate; BB, blueberry treatment; C, control treatment; SEM, standard error of the 
mean 
 2Overall p value for t-TEST with STATISTICA software (Statsoft Inc., Tulsa, OK, US). 
  539 
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Table 3- Characteristics of smoker subjects at baseline  540 
 541 
 542 
 543 
 544 
 545 
 546 
 547 
 548 
 549 
 550 
 551 
 552 
 553 
 554 
 555 
Legend 556 
1N=12. Data are reported as mean ± SEM; SBP, systolic blood pressure; DBP, diastolic 557 
blood pressure; HR, heart rate; RHI, reactive hyperemia index; dAix, digital augmentation 558 
index; dAix@75, digital augmentation index standardized for heart rate of 75 bpm; SEM, 559 
standard error of the mean 560 
  561 
Variables         Mean ± SEM1 
Age (years)                                        24.5 ± 1.9 
Height (cm) 
Weight (kg) 
BMI (kg/m2) 
       180.1 ± 1.3 
         70.7 ± 1.2 
         22.9 ± 1.1 
Smoke (cigarettes/day)           15   ±  0.4 
SBP (mm Hg)        118.2 ± 2.9 
DBP (mm Hg)          75.7 ± 2.7 
HR (beat/min)          64.9 ± 5.1 
RHI 
dAix(%) 
dAix@75 (%) 
         1.47 ± 0.05 
         -12.7 ± 2.5 
        -18.2 ± 5.0         
26 
 
Table 4 - Arterial function and arterial stiffness before and 20 min after smoking a cigarette in 
smokers  
 
                                  Before smoking              20 min After smoking            p value1 
RHI                             1.47 ± 0.05                       1.58 ± 0.07                          0.324 
dAix (%)                      -12.7 ± 2.5                      -15.6 ± 3.5                           0.455 
dAix@75 (%)             -18.2 ± 5.0                        -18.8 ± 4.9                          0.895 
 
Legend  
1 N =12. Data are expressed as means ± SEM. RHI, reactive hyperemia index; dAix, digital 
augmentation index; dAix@75, digital augmentation index standardized for heart rate of 75 bpm. 
1Overall p value for t-TEST with STATISTICA software (Statsoft Inc., Tulsa, OK, US). 562 
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Table 5 – Mean percentage variation (Δ) of systolic blood pressure (SBP), diastolic blood pressure 563 
(DPB) and heart rate (HR) in smokers measured during each treatment.1 564 
 
                                      Δ% S                     Δ% BS                    Δ% CS                      p value2 
SBP                             11.3 ± 3.5                4.13 ± 1.27             5.38 ± 2.52                0.174 
DBP                            13.6 ± 5.5                4.09 ± 3.05              2.35 ± 2.34               0.130 
HR                             15.5 ± 3.7                  9.80 ± 4.50              10.8 ± 5.1                0.961 
 
Legend  
1 N =12. Data are expressed as mean ± SEM. S, smoking treatment; CS, control-drink  + smoking 
treatment; BS, blueberry intake + smoking treatment. SBP, systolic blood pressure; DBP, diastolic 
blood pressure; HR, heart rate;  
 2Overall p value for ANOVA with STATISTICA software (Statsoft Inc., Tulsa, OK, US).  565 
 
  566 
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Figure 1-Experimental designs  567 
 568 
Figure legend 569 
A) non-smokers study: two arms, randomized controlled crossover design; B) smokers study: three 570 
arms, randomized controlled crossover design.   571 
 572 
Figure 2- Mean percent variation of RHI (A), dAix (B), dAix@75(B) measured during blueberry 573 
(BB) and control (C) treatment.1 574 
 575 
Figure legend  576 
1Data are expressed as mean ± SEM. C, control treatment; BB, blueberry treatment; RHI, reactive 577 
hyperemia index; dAix, digital augmentation index; dAix@75, digital augmentation index 578 
standardized for heart rate of 75 bpm. 579 
a,b Graphs with different letters are significantly different from other treatments (p ≤ 0.01). 580 
 581 
Figure 3-Variation of systolic and diastolic blood pressure (3A), and heart rate (3B) during acute 582 
cigarette smoking over time.1  583 
 584 
Figure legend 585 
1Data are expressed as mean ± SEM. SBP, systolic blood pressure; DBP, diastolic blood pressure; 586 
HR, heart rate.  587 
2Overall p value for ANOVA with STATISTICA software (Statsoft Inc., Tulsa, OK, US).  588 
*Data are significantly different. 589 
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Figure 4- Mean percent variation of RHI (A), dAix (B), dAix@75 (C) measured during each 590 
treatment. 591 
 592 
Figure legend 593 
1Data are expressed as mean ± SEM. S, smoking treatment; CS, control-drink + smoking treatment; 594 
BS, blueberry intake + smoking treatment; RHI, reactive hyperemia index; dAix, digital 595 
augmentation index; dAix@75, digital augmentation index standardized  for heart rate of 75 bpm. 596 
a,b Graphs with different letters are significantly different from other treatments (p ≤ 0.01). 597 
 598 
